Immunogenicity of the BNT162b2 vaccine in frail or disabled nursing home residents: COVID‐A study

BACKGROUND/OBJECTIVES: The safety and immunogenicity of the BNT162b2 coronavirus disease 2019 (COVID‐19) vaccine in older adults with different frailty and disability profiles have not been well determined. Our objective was to analyze immunogenicity of the BNT162b2 mRNA COVID‐19 vaccine in older ad...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Am Geriatr Soc
Main Authors: Salmerón Ríos, Sergio, Mas Romero, Marta, Cortés Zamora, Elisa Belén, Tabernero Sahuquillo, María Teresa, Romero Rizos, Luis, Sánchez‐Jurado, Pedro Manuel, Sánchez‐Nievas, Ginés, Señalada, José Joaquín Blas, García Nogueras, Inmaculada, Estrella Cazalla, Juan de Dios, Andrés‐Pretel, Fernando, Murillo Romero, Antonio, Lauschke, Volker Martin, Stebbing, Justin, Abizanda, Pedro
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2021
Assuntos:
COVID‐19‐Related Content
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8250586/
https://ncbi.nlm.nih.gov/pubmed/33768521
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jgs.17153
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados